gusperimus has been researched along with Lupus Erythematosus, Systemic in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dickneite, G; Schorlemmer, HU | 1 |
| Barcellini, W; Beltrami, B; Borghi, MO; Del Papa, N; Fain, C; Meroni, PL; Mottola, L; Nicoletti, F; Schorlemmer, HU | 1 |
| Aoyagi, T; Fujiwara, M; Hagihara, M; Nagatsu, T; Sekiguchi, K; Takeuchi, T | 1 |
| Bartlett, RR; Schorlemmer, HU; Seiler, FR | 1 |
| Abe, F; Hayashi, M; Mae, T; Nemoto, K; Sugawara, Y; Takeuchi, T | 1 |
1 review(s) available for gusperimus and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Preclinical studies with 15-deoxyspergualin in various animal models for autoimmune diseases.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Autoimmune Diseases; Diabetes Mellitus, Type 1; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Guanidines; Lupus Erythematosus, Systemic; Mice; Nephritis; Rats | 1993 |
4 other study(ies) available for gusperimus and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Immunosuppressive activity of 15-deoxyspergualin on normal and autoimmune peripheral blood mononuclear cells.
Topics: Cytokines; DNA; Dose-Response Relationship, Drug; Guanidines; Humans; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; In Vitro Techniques; Lupus Erythematosus, Systemic; Lymphocytes; Monocytes | 1996 |
Effects of deoxyspergualin on dipeptidyl peptidase-II and -IV in the spleen of BXSB mice and MRL/lpr mice during the development of the lupus erythematosus-like syndrome.
Topics: Animals; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Disease Models, Animal; Female; Guanidines; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Mice; Mice, Inbred Strains; Spleen | 1992 |
15-Deoxyspergualin (15-DOS) has a curative effect on the development of SLE-like autoimmune disease in MRL/1 mice.
Topics: Animals; Arthritis, Rheumatoid; Autoantibodies; Autoimmune Diseases; Female; Glomerulonephritis; Guanidines; Immunosuppressive Agents; Injections, Intraperitoneal; Lupus Erythematosus, Systemic; Male; Mice; Mice, Inbred Strains; Rheumatoid Factor | 1991 |
Deoxyspergualin therapy in autoimmune MRL/1pr mice suffering advanced lupus-like disease.
Topics: Animals; Autoimmune Diseases; Blood Urea Nitrogen; Dose-Response Relationship, Drug; Glomerulonephritis; Guanidines; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Mice; Uremia | 1990 |